Integrated Advisors Network’s Humacyte HUMA Stock Holding History

Integrated Advisors Network’s Portfolio HUMA Stock Details HUMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-86,782	Closed	-$151K	–	762
2025 Q3	$151K	Buy	+86,782	New	+$170K	0.01%	760

Other funds holding HUMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Integrated Advisors Network's HUMA Position: Q4 2025 in Review

Integrated Advisors Network sold out of Humacyte (HUMA) in Q4 2025, closing a stake of 86,782 shares — an estimated $151K sold.

Integrated Advisors Network first reported a position in HUMA in Q3 2025 and held it in 1 quarter. The position peaked at $151K in Q3 2025. 147 funds tracked by Wall St. Rank hold HUMA as of Q4 2025.

Integrated Advisors Network reported no remaining Humacyte position as of Q4 2025 after selling out during the quarter.
Integrated Advisors Network sold 86,782 Humacyte shares in Q4 2025, an estimated $151K.
Integrated Advisors Network first reported a position in Humacyte in Q3 2025 and held it in 1 quarter.
Integrated Advisors Network's Humacyte position peaked at $151K in Q3 2025.
147 funds tracked by Wall St. Rank held Humacyte as of Q4 2025.

Based on Integrated Advisors Network's 13F filing for Q4 2025, filed 17 Feb 2026.